CAS 102507-71-1: Tigemonam
Formula:C12H15N5O9S2
InChI:InChI=1S/C12H15N5O9S2/c1-12(2)8(10(21)17(12)26-28(22,23)24)15-9(20)7(16-25-3-6(18)19)5-4-27-11(13)14-5/h4,8H,3H2,1-2H3,(H2,13,14)(H,15,20)(H,18,19)(H,22,23,24)/b16-7-/t8-/m1/s1
InChI key:InChIKey=VAMSVIZLXJOLHZ-QWFSEIHXSA-N
SMILES:N(C(/C(=N\OCC(O)=O)/C=1N=C(N)SC1)=O)[C@H]2C(C)(C)N(OS(=O)(=O)O)C2=O
Synonyms:- ({[(1Z)-1-(2-amino-1,3-thiazol-4-yl)-2-{[(3S)-2,2-dimethyl-4-oxo-1-(sulfooxy)azetidin-3-yl]amino}-2-oxoethylidene]amino}oxy)acetic acid
- 2-[[(Z)-[1-(2-Amino-4-thiazolyl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]acetic acid
- Acetic acid, (((1-(2-amino-4-thiazolyl)-2-((2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl)amino)-2-oxoethylidene)amino)oxy)-, (S-(Z))-
- Acetic acid, 2-[[(Z)-[1-(2-amino-4-thiazolyl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-
- Acetic acid, [[(Z)-[1-(2-amino-4-thiazolyl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-
- Tigemonam [INN]
- Tigemonamum
- Tigemonamum [Latin]
- Tigemonam
Sort by
Found 3 products.
Tigemonam
CAS:Tigemonam is a synthetic beta-lactam antibiotic, which is derived from chemical synthesis processes. This compound operates by inhibiting bacterial cell wall synthesis, specifically targeting the penicillin-binding proteins (PBPs). The disruption of the cell wall synthesis ultimately leads to cell lysis and death of the bacteria, making it effective primarily against gram-negative bacterial infections. The primary uses and applications of Tigemonam involve its role as an antimicrobial agent in treating infections caused by susceptible gram-negative organisms. Its specificity for certain beta-lactamase-producing pathogens often makes it a choice in clinical scenarios where resistance to other antibiotics poses a significant challenge. Researchers might find Tigemonam particularly valuable in studying antibiotic resistance mechanisms and in exploring new treatment regimens for multidrug-resistant bacterial strains. The compound's pharmacokinetic properties, such as stability and tissue penetration, offer additional insights into optimizing dosage and minimizing adverse effects in clinical settings.Formula:C12H15N5O9S2Purity:Min. 95%Molecular weight:437.41 g/molTigemonam
CAS:Tigemonam is a monobactam, a novel orally administered monobactam that protects against gram-negative aerobic bacterial pathogens. Cost-effective and quality-assured.Formula:C12H15N5O9S2Purity:98.12% - 99.03%Color and Shape:SolidMolecular weight:437.41
